NeuroBo Pharmaceuticals, Inc. (NRBO) has a market capitalization of $20.33M and trades at $2.36.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.3, Earnings Per Share (EPS) of $-7.35.
The stock has a beta of -0.28, operates in the Healthcare sector.
